Mitsubishi UFJ Trust & Banking’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105M Buy
1,736,084
+136,480
+9% +$7.96M 0.26% 85
2025
Q4
$86.3M Sell
1,599,604
-1,069,020
-40% -$51.4M 0.21% 103
2025
Q3
$120M Buy
2,668,624
+287,867
+12% +$13.4M 0.26% 79
2025
Q2
$110M Buy
2,380,757
+82,453
+4% +$4.05M 0.26% 89
2025
Q1
$140M Sell
2,298,304
-244,658
-10% -$14.3M 0.37% 50
2024
Q4
$144M Buy
2,542,962
+186,008
+8% +$10.4M 0.34% 58
2024
Q3
$122M Buy
2,356,954
+130,753
+6% +$6.13M 0.28% 76
2024
Q2
$92.5M Sell
2,226,201
-362,384
-14% -$16.2M 0.22% 97
2024
Q1
$139M Sell
2,588,585
-47,319
-2% -$2.41M 0.32% 71
2023
Q4
$135M Sell
2,635,904
-109,887
-4% -$5.77M 0.32% 70
2023
Q3
$159M Sell
2,745,791
-74,215
-3% -$4.55M 0.4% 54
2023
Q2
$180M Buy
2,820,006
+245,172
+10% +$16.4M 0.42% 52
2023
Q1
$178M Buy
2,574,834
+339,209
+15% +$23.9M 0.43% 49
2022
Q4
$161M Buy
2,235,625
+207,405
+10% +$15.6M 0.42% 50
2022
Q3
$144M Sell
2,028,220
-57,369
-3% -$4.16M 0.4% 52
2022
Q2
$161M Buy
2,085,589
+688,663
+49% +$52.4M 0.41% 53
2022
Q1
$102M Sell
1,396,926
-7,824
-0.6% -$525K 0.23% 103
2021
Q4
$87.6M Sell
1,404,750
-62,632
-4% -$3.67M 0.18% 136
2021
Q3
$86.8M Sell
1,467,382
-32,310
-2% -$2.13M 0.19% 131
2021
Q2
$100M Sell
1,499,692
-137,705
-8% -$8.98M 0.21% 122
2021
Q1
$103M Sell
1,637,397
-318,609
-16% -$19.8M 0.23% 111
2020
Q4
$121M Sell
1,956,006
-125,232
-6% -$7.7M 0.24% 97
2020
Q3
$125M Sell
2,081,238
-192,285
-8% -$11.6M 0.28% 84
2020
Q2
$134M Sell
2,273,523
-315,430
-12% -$18.9M 0.32% 70
2020
Q1
$144M Buy
2,588,953
+126,953
+5% +$7.76M 0.42% 50
2019
Q4
$158M Buy
2,462,000
+670,542
+37% +$38.4M 0.38% 58
2019
Q3
$90M Buy
1,791,458
+103,053
+6% +$4.84M 0.23% 102
2019
Q2
$76.1M Buy
1,688,405
+200,045
+13% +$9.32M 0.26% 81
2019
Q1
$71.2M Buy
1,488,360
+43,561
+3% +$2.17M 0.26% 83
2018
Q4
$75.1M Buy
1,444,799
+41,448
+3% +$2.23M 0.31% 70
2018
Q3
$87.1M Sell
1,403,351
-2,064,008
-60% -$122M 0.31% 69
2018
Q2
$192M Buy
3,467,359
+68,236
+2% +$3.69M 0.33% 68
2018
Q1
$215M Buy
3,399,123
+23,876
+0.7% +$1.54M 0.38% 51
2017
Q4
$207M Sell
3,375,247
-12,756
-0.4% -$798K 0.36% 58
2017
Q3
$216M Sell
3,388,003
-46,150
-1% -$2.69M 0.4% 53
2017
Q2
$191M Buy
3,434,153
+46,301
+1% +$2.52M 0.37% 50
2017
Q1
$184M Sell
3,387,852
-127,970
-4% -$7.02M 0.37% 55
2016
Q4
$205M Sell
3,515,822
-170,034
-5% -$9.3M 0.43% 46
2016
Q3
$199M Buy
3,685,856
+195,892
+6% +$12.6M 0.41% 46
2016
Q2
$257M Buy
3,489,964
+89,624
+3% +$6.33M 0.56% 35
2016
Q1
$217M Buy
3,400,340
+43,689
+1% +$2.76M 0.49% 43
2015
Q4
$231M Buy
3,356,651
+13,150
+0.4% +$869K 0.53% 41
2015
Q3
$198M Buy
3,343,501
+23,503
+0.7% +$1.49M 0.48% 43
2015
Q2
$221M Buy
3,319,998
+65,457
+2% +$4.31M 0.51% 42
2015
Q1
$210M Sell
3,254,541
-30,748
-0.9% -$1.92M 0.49% 40
2014
Q4
$194M Buy
3,285,289
+7,136
+0.2% +$402K 0.46% 44
2014
Q3
$168M Sell
3,278,153
-101,155
-3% -$5.05M 0.41% 50
2014
Q2
$164M Buy
3,379,308
+153,079
+5% +$7.54M 0.38% 56
2014
Q1
$168M Sell
3,226,229
-466,753
-13% -$24.8M 0.41% 50
2013
Q4
$196M Sell
3,692,982
-359,247
-9% -$18.3M 0.48% 40
2013
Q3
$188M Buy
4,052,229
+419,098
+12% +$18.4M 0.5% 38
2013
Q2
$162M Buy
+3,633,131
New +$158M 0.46% 38

Other funds holding BMY

Mitsubishi UFJ Trust & Banking's BMY Position: Q1 2026 in Review

Mitsubishi UFJ Trust & Banking increased its Bristol-Myers Squibb (BMY) stake by 8.5% in Q1 2026, buying an estimated $7.96M and bringing the position to 1,736,084 shares worth $105M. The position accounts for 0.26% of the portfolio, ranked #85.

Mitsubishi UFJ Trust & Banking first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $257M in Q2 2016. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Mitsubishi UFJ Trust & Banking held 1,736,084 shares of Bristol-Myers Squibb worth $105M as of Q1 2026.
  • Mitsubishi UFJ Trust & Banking bought 136,480 Bristol-Myers Squibb shares in Q1 2026, an estimated $7.96M.
  • Bristol-Myers Squibb made up 0.26% of Mitsubishi UFJ Trust & Banking's portfolio in Q1 2026, its #85 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Mitsubishi UFJ Trust & Banking's Bristol-Myers Squibb position peaked at $257M in Q2 2016.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q1 2026, filed 12 May 2026.